| Document |
Document Title |
|
WO/2024/011414A1 |
Disclosed in the present invention is a reaction method for secondary amine and o-diiodobenzene, comprising: reacting secondary amine with o-diiodobenzene in the presence of an alkali metal hydride or a Grignard reagent to complete the r...
|
|
WO/2023/116397A1 |
Disclosed is an innate immune-activating drug, which has broad-spectrum antiviral activity, immune adjuvant activity, promotive immunotherapy and anti-tumor activity. Specifically, disclosed are use of a compound of formula I or a tautom...
|
|
WO/2023/098740A1 |
The present invention belongs to the technical field of photoelectric materials, and particularly relates to an organic room-temperature electrophosphorescent material, and a preparation method therefor and an organic electroluminescent ...
|
|
WO/2022/132918A9 |
A method for treating or inhibiting cytomegalovirus infection, including administrating an effective amount of a class of small molecules targeting protein phosphatase 1 (PP1) to a subject in need thereof. A method for inhibiting replica...
|
|
WO/2023/054344A1 |
The problem to be solved by the present invention is to provide: a compound which is useful as a hole transport material for photoelectric conversion elements that are capable of efficiently taking out electric current; and a photoelectr...
|
|
WO/2023/033165A1 |
A compound represented by formula [I] (in the formula, R12, R13, R14, R15 and R16 are the same or different, and are hydrogen, halogen, a C1-6 alkyl optionally substituted with halogen, or a C1-6 alkoxy optionally substituted with haloge...
|
|
WO/2023/001338A1 |
The invention relates to a compound, a rubber blend containing said compound, a vehicle tire comprising the rubber blend in at least one component, a process for producing the compound and the use of the compound as ageing protectant and...
|
|
WO/2023/273384A1 |
Provided in the present disclosure are a thermally activated delayed fluorescent material, an organic light-emitting device and a display apparatus. The energy level difference between a singlet energy level and a triplet energy level of...
|
|
WO/2022/250971A1 |
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a tetrahydroacridine (or similar) structure, an acridine (or similar) structure, a benzonaphthyridine (o...
|
|
WO/2022/211281A1 |
The present invention relates to a heterocyclic compound represented by chemical formula 1, an organic light-emitting device comprising same, a manufacturing method therefor, and a composition for an organic material layer.
|
|
WO/2022/206829A1 |
The present application relates to the field of electroluminescence, and discloses a compound, an organic electroluminescent device and a display apparatus. The structural formulae of the compound are represented by formulae (I) to (III)...
|
|
WO/2022/191092A1 |
The present invention addresses the problem of providing a new method for increasing the intracerebral histamine concentration. The present invention provides a compound represented by general formula (I) or a salt thereof. [In the formu...
|
|
WO/2022/161556A1 |
The present invention provides compounds of general formula I, wherein n is 1, 2 or 3, R1 is selected from the group -CH3; –OCH3; -Br; -Cl; -F; phenoxy; 1-CH3-phenoxy; 1-OCH3-phenoxy; 2-OCH3-phenoxy; 3-CH3-phenoxy; 3-Cl-phenoxy; 3-C(CH...
|
|
WO/2022/130089A1 |
Described are visible light absorbing compounds. The compounds have a visible light absorption maximum between 430 and 480 nm and a full width half maximum (FWHM) at the visible light absorption maximum of at least 35 nm and up to 150 na...
|
|
WO/2022/107755A1 |
The present invention provides: a novel acridinium salt expressed by formula (I); and a method for producing this novel acridinium salt. (In the formula, R1 represents a C1-C6 alkyl group or a C1-C6 alkyloxy group; R2 represents a hydrog...
|
|
WO/2022/099810A1 |
A tetraphenylethylene compound, an application thereof, and an electronic device using same. The structural general formula of the tetraphenylethylene compound is shown in formula 1. The tetraphenylethylene compound contains an aromatic ...
|
|
WO/2022/100704A1 |
The present application relates to the field of electroluminescence, and disclosed are a compound, an organic electroluminescent apparatus and a display device. The structural formula of the compound is represented by formula (I). The or...
|
|
WO/2022/079055A1 |
The present invention belongs to the field of catalytic chemistry, and more specifically to catalysed oxidation of lignin. It also relates to synthesis of catalyst compounds. The present invention relates to new acridinium-based photored...
|
|
WO/2021/235546A1 |
The fluorenylidene-acridane derivative has a structure represented by formula (1) (where at least one among R1-R16 is an organic group, the remainder being hydrogen atoms or organic groups, and R17 is a hydrogen atom or an organic group).
|
|
WO/2021/231893A1 |
The present disclosure relates to compounds that inhibit Ly6K. Also disclosed are methods of using such compounds to inhibit activity of Ly6K protein in a cell, to inhibit cell proliferation, to modulate expression of a gene in a cell, t...
|
|
WO/2020/248075A9 |
The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ERCC1-XP...
|
|
WO/2021/204197A1 |
The present invention relates to the technical field of biological medicines, and provides an application of an acridinedione compound in preparation of anti-diabetic drugs. The present invention is the first to demonstrate that the acri...
|
|
WO/2021/189553A1 |
A preparation method for a thermally activated delayed fluorescence material, comprising: adding a catalyst, an alkaline substance and a solvent into a first reactant which is a bromide of cyclopentane[def]fluoren-4,8-dione and a second ...
|
|
WO/2021/157642A1 |
The present invention improves the light emission efficiency, driving voltage, and lifespan of an organic electroluminescent element using a delayed fluorescent material. A host material for a delayed fluorescent material and comprising ...
|
|
WO/2021/157593A1 |
Superior durability is demonstrated by an organic light emitting element that uses a light emitting composition including both a first compound with a PBHT value greater than 0.730 and a second compound for which ES1 is smaller than for ...
|
|
WO/2021/156323A1 |
The present application relates to an amine compound, which is suitable for use in electronic devices, in particular organic electroluminescent devices (OLEDs). Furthermore, it relates to electronic devices comprising the compound, in pa...
|
|
WO/2021/142065A1 |
This disclosure provides a cridin-9-yl-amine, quinolin-9-yl-amine, 1- amino-9H-thioxanthene-9-one and benzo[b][l,5]naphthyridin-10- yl-amine derivatives and structurally related compounds for use as autophagy inhibitors for treating canc...
|
|
WO/2021/125834A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
|
WO/2021/104224A1 |
An EO/PO-modified 9-phenylacridine photosensitizer, having a structure as shown in general formula (I). When the photosensitizer is applied to a photosensitive resin composition, the composition has the characteristics of high photosensi...
|
|
WO/2021/103319A1 |
Disclosed is a hole transport material taking ethylene bis-acridine as a core. The hole transport material has a structure as shown in general formula (I), and has a migration rate suitable for an energy level of the highest occupied mol...
|
|
WO/2021/096285A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.
|
|
WO/2021/086234A1 |
The invention relates to chemistry, pharmaceuticals and medicine, and specifically to a new chemical compound of the class of derivatives of 9-oxoacridinyl-10-acetate: L-lysine 9-oxoacridinyl-10-acetate, which stimulates production of in...
|
|
WO/2021/036851A1 |
The present disclosure relates to the technical field of electronic components, and provided therein are a nitrogen-containing compound represented by formula (I), an organic electroluminescent device and a photoelectric conversion devic...
|
|
WO/2021/037179A1 |
A compound of formula I or a pharmaceutically acceptable salt, solvate, or prodrug thereof, a preparation method therefor, a pharmaceutical composition comprising same, and an application thereof. The compound can be used to prepare a dr...
|
|
WO/2021/021725A1 |
This disclosure provides compositions of electrochromic dyes, functionalized electrochromic dyes and dye macromers which may be incorporated into electrochromic devices with tailored optical properties. The disclosure provides an electro...
|
|
WO/2020/261021A1 |
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...
|
|
WO/2020/243037A1 |
The disclosure is directed to bisaminoquinolines and bisaminoacridines as autophagy inhibitors for treating cancer and other disease states and conditions.
|
|
WO/2020/237901A1 |
The present invention relates to the technical field of organic light-emitting materials, and specifically relates to a thermally activated delayed fluorescence blue light material, a synthesis method therefor and use thereof. The therma...
|
|
WO/2020/228359A1 |
The present invention relates to the field of organic optoelectronic materials, and disclosed are an organic light-emitting material containing tetraphenylbenzene, preparation, and an application. The organic light-emitting material cont...
|
|
WO/2020/232375A1 |
Compounds of Formulae I, II, their pharmaceutically acceptable salts or esters thereof capable of binding to and modulating the activity of a stimulator of interferon genes (STING) protein are provided. Methods involving compounds of For...
|
|
WO/2020/216708A1 |
The present invention relates to a compound having the formula (I), an organic semiconducting layer comprising the same, an organic electronic device comprising the same, a display device comprising the same and a lighting device compris...
|
|
WO/2020/212408A1 |
The present invention relates to an organic semiconducting material comprising a compound comprising at least one dibenzo [c,h) acridine group and at least one CN-group, organic electronic devices comprising the same and display devices ...
|
|
WO/2020/211124A1 |
The present invention relates to a thermally activated delayed fluorescence material, a preparation method therefor, and an organic light-emitting diode device. The structural general formula of the thermally activated delayed fluorescen...
|
|
WO/2020/211122A1 |
The present invention relates to a bipolar thermally activated delayed fluorescence material, a preparation method therefor, and an organic electroluminescent diode device. The structure general formula of the bipolar thermally activated...
|
|
WO/2020/211121A1 |
The present invention relates to a thermally activated delayed fluorescence material, a preparation method therefor, and an organic electroluminescent diode device, the structural general formula of the thermally activated delayed fluore...
|
|
WO/2020/205765A1 |
The present invention provides photocatalysts, methods for their preparation, and methods for preparing linear polymers with high propagation rate.
|
|
WO/2020/199945A1 |
The present invention relates to the technical field of medicine, and discloses a compound as shown in formula (I) and a preparation method therefor, a pharmaceutical composition and the use thereof. In particular, further disclosed in t...
|
|
WO/2020/191866A1 |
A thermally activated delayed fluorescent material having a chemical structural formula (A), the R group being a diphenylamine group. An efficient deep blue thermally activated delayed fluorescent material is produced by using tetrastyre...
|
|
WO/2020/192042A1 |
Provided are an electroluminescent material, a method for preparing the electroluminescent material, and a light-emitting device containing the electroluminescent material. Strong electron withdrawing groups such as a cyano group, pyridi...
|
|
WO/2020/156360A1 |
A cholinesterase inhibitor polymorph, wherein specifically disclosed are a succinic octahydroacridine polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound succinic octahydr...
|
